| ECT | Electroconvulsive therapy; |
| TRD | Treatment-resistant depression; |
| MADRS | Montgomery–Åsberg Depression Rating Scale; |
| MDD | Major depressive disorder; |
| ECS | Electroconvulsive stimulation; |
| E2F1 | Early region 2 promoter transcription factor 1; |
| EDTA | Ethylenediaminetetraacetic acid; |
| PBMCs | Peripheral blood mononuclear cells; |
| FSB | 3,3′-[(2-fluoro-1,4-phenylene)di-(1E)-2,1-ethenediyl]bis-6-hydroxy-benzoic acid; |
| DMSO | Dimethyl sulfoxide; |
| RT-PCR | Reverse transcription polymerase chain reaction; |
| MOMP | Mitochondrial outer membrane permeabilization; |
| AMPK | Adenosine monophosphate-activated protein kinase; |
| RUS | Repeated unpredictable stress; |
| Cdk2-pRB-E2F1 | Cyclin-dependent kinase 2–retinoblastoma protein–E2F1 pathway. |